• Citer

Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.

par Rossebø, Anne B;Pedersen, Terje R.;Boman, Kurt;Brudi, Philippe;Chambers, John B;Egstrup, Kenneth;Gerdts, Eva;Gohlke-Bärwolf, Christa;Holme, Ingar;Kesäniemi, Antero YA;Malbecq, William ;Nienaber, Christoph A;Ray, Simon;Skjaerpe, Terje;Wachtell, Kristian;Willenheimer, Ronnie;SEAS Investigators,
Référence The New England journal of medicine, 359, 13, page (1343-1356)
Publication Publié, 2008-09

Article révisé par les pairs

• Détails
• Contenu

Titre:	Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis.
Auteur:	Rossebø, Anne B; Pedersen, Terje R.; Boman, Kurt; Brudi, Philippe; Chambers, John B; Egstrup, Kenneth; Gerdts, Eva; Gohlke-Bärwolf, Christa; Holme, Ingar; Kesäniemi, Antero YA; Malbecq, William; Nienaber, Christoph A; Ray, Simon; Skjaerpe, Terje; Wachtell, Kristian; Willenheimer, Ronnie; SEAS Investigators,
Informations sur la publication:	The New England journal of medicine, 359, 13, page (1343-1356)
Statut de publication:	Publié, 2008-09
Sujet CREF:	Sciences biomédicales
MeSH keywords:	Adult
	Aged
	Aged, 80 and over
	Alanine Transaminase -- blood
	Anticholesteremic Agents -- adverse effects -- therapeutic use
	Aortic Valve Stenosis -- drug therapy -- surgery
	Aspartate Aminotransferases -- blood
	Azetidines -- adverse effects -- therapeutic use
	Cardiovascular Diseases -- epidemiology -- mortality -- prevention & control
	Cholesterol, LDL -- blood
	Coronary Artery Bypass
	Disease Progression
	Double-Blind Method
	Drug Therapy, Combination
	Ezetimibe
	Female
	Follow-Up Studies
	Heart Valve Prosthesis Implantation -- statistics & numerical data
	Humans
	Kaplan-Meier Estimate
	Male
	Neoplasms -- chemically induced
	Simvastatin -- adverse effects -- therapeutic use
	Treatment Outcome
Langue:	Anglais
Identificateurs:	urn:issn:0028-4793
	info:doi/10.1056/NEJMoa0804602
	info:pii/NEJMoa0804602
	info:pmid/18765433